In-Depth Insights into the Intravenous Fluid Transfer Drug Devices Market: Growth, Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the intravenous fluid transfer drug devices market?
The intravenous fluid transfer drug devices market has seen consistent growth, increasing from $7.38 billion in 2024 to $7.85 billion in 2025 at a CAGR of 6.4%. Its historical growth was influenced by rising demand for efficient medical supplies, expansion in healthcare infrastructure, more surgical interventions requiring IV support, evolving policy changes, and new drugs requiring precise administration.
What will be the intravenous fluid transfer drug devices market size in the future?
The intravenous fluid transfer drug devices market is set to grow, reaching $9.96 billion by 2029 with a CAGR of 6.1%. Growth will be driven by increasing demand for portable medical devices, higher investments in advanced healthcare technologies, cost-effective solutions, and non-hospital treatment settings. Key trends include smart technology integration, automated IV fluid transfer adoption, enhanced safety features to minimize medication errors, and compatibility with remote monitoring systems.
Get your intravenous fluid transfer drug devices market report here!
What main drivers are fueling expansion in the intravenous fluid transfer drug devices market?
The rising hospitalization rate is projected to boost the growth of the intravenous fluid transfer drug device market. This increase is due to an aging population, chronic illnesses, better diagnostic tools, and advancements in healthcare access. Intravenous fluid transfer systems precisely administer fluids and medications to hospitalized patients. For instance, the American Hospital Association reported in May 2023 that U.S. hospital admissions reached 34,011,386 in 2023, a rise from 33,356,853 in 2022. Therefore, the growing hospitalization rate is expected to propel the intravenous fluid transfer drug device market.
What key areas define the segmentation of the global intravenous fluid transfer drug devices market?
The intravenous fluid transfer drug devicesmarket covered in this report is segmented –
1) By Type: Infusion Bags, Infusion Devices, Other Types
2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications
3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors
Subsegments:
1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags
2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices
3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices.
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19535&type=smp
Who are the dominant players expanding their reach in the intravenous fluid transfer drug devices market?
Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., 3M Company, Medtronic plc, Becton, Dickinson and Company, Baxter International Inc., B. Braun Holding GmbH & Co. KG, Fresenius Kabi AG, Mindray Medical International Limited, Nipro Corporation, Moog Inc., West Pharmaceutical Services Inc., ICU Medical Inc., Insulet Corporation, Merit Medical Systems Inc., Avanos Medical Inc., Vygon SAS, NxStage Medical Inc., AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Zyno Medical LLC, Sippex, Arcomed AG
How are evolving market trends shaping intravenous fluid transfer drug devices Strategies?
Notable corporations within the intravenous fluid drug transfer device market are innovating modular and all-inclusive infusion systems equipped with auto-identification features to bolster precision, promote safety of patients, and simplify the administration of medications and fluids. These infusion systems have the capability to automatically match and verify medications to the intended patient with either RFID technology or barcode scanning. For instance, in July 2023, Becton, Dickinson, and Company, a company specializing in medical devices from the United States, attained FDA 510(k) approval for the revised version of their BD Alaris Infusion System. This updated version of the BD Alaris Infusion System comprises restructured hardware for its Point-of-Care Unit (PCU), like large volume pumps, syringe pumps, PCA pumps, respiratory monitoring, and auto-identification modules. It further incorporates an upgraded software version that comes with enhanced features for cybersecurity and interoperability, enabling effortless incorporation with prevalent electronic medical record (EMR) systems, thus advocating for digital, interconnected healthcare.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19535
Which regions are emerging as leaders in the intravenous fluid transfer drug devices market?
North America was the largest region in the intravenous fluid transfer drug devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Antiglaucoma Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antiglaucoma-drugs-global-market-report
Drug Device Combination Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-device-combination-global-market-report
Insulin Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
